PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
Table 2
Correlation analyses of PCSK9 with genes involved in the inflammatory response in EAT.
Genes
Family group
Function
Correlation coefficient, value
C5
Regulation of inflammation
Member of the complement system: mediator of local inflammatory process
0.446, 0.038
CCL11
Chemokine
Chemotactic activity for eosinophils
0.508, 0.016
CCL20
Chemokine
Chemotactic activity for lymphocytes
0.470, 0.028
CCL21
Chemokine
Chemotactic for thymocytes and activated T-cells, but not for B-cells, macrophages, or neutrophils
-0.447, 0.037
CCR6
Chemokine receptor
Ligand for macrophage inflammatory protein 3 alpha
0.416, 0.050
CEBPB
Regulation of inflammation
Transcription factor regulating the expression of genes involved in immune and inflammatory responses
0.433, 0.044
CSF3
Regulation of inflammation
It control of production, differentiation, and function of granulocytes
0.423, 0.049
CXCL2
Regulation of inflammation
Produced by activated monocytes and neutrophils and expressed at sites of inflammation and may suppress progenitor cell proliferation
0.459, 0.032
CXCL6
Regulation of inflammation
Chemotactic for neutrophil granulocytes
0.459, 0.031
CXCL10
Regulation of inflammation
Proinflammatory cytokine that is involved in a wide variety of processes such as chemotaxis, differentiation, and activation of peripheral immune cells, regulation of cell growth, apoptosis, and modulation of angiostatic effects
0.456, 0.033
CXCL13
Regulation of inflammation
Chemotactic for B-lymphocytes
0.591, 0.004
CXCR5
Regulation of inflammation
Binds to B-lymphocyte chemoattractant (BLC) and is involved in B-cell migration
0.431, 0.045
FASLG
Other molecules
Immune system regulation, including activation-induced cell death of T-cells and cytotoxic T lymphocyte-induced cell death
0.634, 0.002
IFNγ
Other molecules
Potent activator of macrophages
0.443, 0.039
IL1β
Interleukins
Induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, and B-cell activation
0.445, 0.038
IL10
Interleukins
Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation
0.421, 0.050
IL17A
Interleukins
Proinflammatory cytokine produced by activated T-cells
0.476, 0.025
IL17F
Interleukins
Expressed by activated T-cells and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF
0.499, 0.018
IL33
Interleukins
Acts as a chemoattractant for Th2 cells and may function as an “alarmin,” that amplifies immune responses during tissue injury
-0.429, 0.046
KNG1
Other molecules
Mediator of inflammation
0.439, 0.041
RIPK4
Regulation of inflammation
Activator of NF-kappa-B
0.572, 0.005
TLR9
Regulation of inflammation
TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion, and the inflammatory response
0.431, 0.046
TLR10
Regulation of inflammation
Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion, and the inflammatory response
0.484, 0.027
TNFSF9
Other molecules
Induces the proliferation of activated peripheral blood T-cells
0.435, 0.043
The table reports correlations of PCSK9 level with genes involved in the inflammatory response in EAT. Spearman’s correlation coefficients and corresponding values are reported.